Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Bayer is 0.2% (very low). The company has been active since 1961 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Trust signals
2 signalsAdministrative Flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 16-06-2025 | 2025-00154661 |
| 31-12-2024 | ander | 18-06-2025 | 2025-00160402 |
| 31-12-2023 | volledig | 10-06-2024 | 2024-00130766 |
| 31-12-2023 | ander | 21-06-2024 | 2024-00173020 |
| 31-12-2022 | volledig | 06-06-2023 | 2023-00111908 |
| 31-12-2022 | ander | 06-06-2023 | 2023-00112224 |
| 31-12-2021 | volledig | 09-06-2022 | 2022-20059369 |
| 31-12-2021 | consolidatie | 10-06-2022 | 2022-20062218 |
| 31-12-2020 | volledig | 10-06-2021 | 2021-20600396 |
| 31-12-2020 | ander | 11-06-2021 | 2021-20100584 |
Structure & network
Locations & real estate
Establishment units
2 locationsReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23015B0163/00D003 | Flanders | 2.7 ha | 1 · 9,977 m² | - |
| 21805E0283/00C000 | Brussels | 3,919 m² | 1 · 1,800 m² | 58.6 m · 15 fl. |
Publications
Lifecycle & Insolvency Signals
Belgisch Staatsblad · acts
26 acts12-08-2025 1 director appointed, 1 resigning
- Tom Van Asbroeck, Raad van bestuur, gedelegeerd bestuurder
- Patrick Lennaerts, Raad van bestuur, gedelegeerd bestuurder
03-09-2024 Werner De Prins resigns as raad van bestuur
23-08-2024 General meeting · Board meeting · Officer appointment · Officer reappointment
- Publication: 23/08/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 19/06/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 13/03/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 15/05/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2024-03-13 · Bayer N.V.
- Officer reappointment: role: bestuurder, start_date: 2024-03-13 · AbbVie N.V.
- Officer reappointment: role: bestuurder, start_date: 2024-03-13 · Eli Lilly Benelux N.V.
- Officer reappointment: role: bestuurder, start_date: 2024-03-13 · Pfizer N.V.
- Officer reappointment: role: bestuurder, start_date: 2024-03-13 · GlaxoSmithKline Pharmaceuticals N.V.
- Officer resignation: date: 2024-03-13, role: bestuurder · Takeda Belgium N.V.
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2024-05-15 · An Van Gerven
- Permanent representative · Werner De Prins
- Permanent representative: start_date: 24/05/2024 · Bart Vermeulen
- Permanent representative: start_date: 14/06/2024 · Niels Hessmann
- Statute amendment · Algemene Vereniging van de Geneesmiddelenindustrie
23-08-2024 Act object · General meeting · Officer appointment · Officer reappointment
- Act object: Nomination administrateurs - nomination vice-présidente Conseil d'administration - modifications aux statuts - nouveaux représentants permanents des administrateurs · Association Générale de l'Industrie du Médicament
- Publication: 23/08/2024 · Association Générale de l'Industrie du Médicament
- Filing: 19/06/2024 · Association Générale de l'Industrie du Médicament
- General meeting: 13/03/2024 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2024-03-13 · Bayer S.A.
- Officer reappointment: role: administrateur, start_date: 2024-03-13 · AbbVie S.A.
- Officer reappointment: role: administrateur, start_date: 2024-03-13 · Eli Lilly Benelux S.A.
- Officer reappointment: role: administrateur, start_date: 2024-03-13 · Pfizer S.A.
- Officer reappointment: role: administrateur, start_date: 2024-03-13 · GlaxoSmithKline Pharmaceuticals S.A.
- Officer resignation: date: 2024-03-13, role: administrateur · Takeda Belgium S.A.
- Statute amendment: Modifications aux statuts approuvées par l'AGE du 13 mars 2024 (articles 2, 5, 9, 12, 16, 28 et dispositions transitoires) · Association Générale de l'Industrie du Médicament
- Board meeting: 15/05/2024 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Vice-Présidente, start_date: 2024-05-15 · An Van Gerven
- Permanent representative · Werner De Prins
- Permanent representative: start_date: 24/05/2024 · Bart Vermeulen
- Permanent representative: start_date: 14/06/2024 · Niels Hessmann
24-07-2024 2 directors appointed, 1 resigning
- Niels Hessmann, Raad van bestuur
- Patrick Lennaerts, Gedelegeerd bestuurder
- Natasja Mooij, Raad van bestuur
17-07-2024 Articles of association amended
19-06-2024 Registered office moved from Diegem to Machelen
- Jan Mommaertslaan 14, 1831 Diegem → Kouterveldstraat 7A 301, 1831 Machelen
31-05-2024 Capital decrease of €3,787,000,000 to €3,192,978,937.79
23-05-2024 Registered office moved from Diegem to Machelen
- Jan Mommaertslaan 14, 1831 Diegem → Kouterveldstraat 7A 301, 1831 Machelen
23-11-2023 Articles of association amended
27-10-2023 2 directors appointed
- Deloitte Bedrijfsrevisoren CVBA, Auditor
- Patrick Lennaerts, Board member
09-11-2021 Werner De Prins appointed as managing director
13-07-2021 Deloitte Bedrijfsrevisoren CVBA appointed as statutory auditor
09-12-2020 1 director appointed, 1 resigning
07-08-2019 1 director appointed, 1 resigning
02-01-2019 1 director appointed, 1 resigning
27-07-2017 1 director appointed, 1 resigning
- Deloitte Bedrijfsrevisoren, Commissaris
- PwC Bedrijfsrevisoren bcvba, Commissaris
19-12-2016 Articles of association amended
13-10-2016 Publication in the Belgian Official Gazette, Miscellaneous
04-10-2016 2 directors appointed
- BCVBA PwC Bedrijfsrevisoren, Commissaris
- Romain Seffer, Vertegenwoordiger commissaris
Analysis
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | Bayer |